Compare Avience Biomedi. with Similar Stocks
Total Returns (Price + Dividend) 
Company does not have enough history
Risk Adjusted Returns v/s 
Returns Beta
Beta has not been calculated since enough price history is not available
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No Upcoming Board Meetings
No Dividend history available
No Splits history available
No Bonus history available
No Rights history available
Quality key factors 
Factor
Value
Sales Growth (5y)
0
EBIT Growth (5y)
0
EBIT to Interest (avg)
8.16
Debt to EBITDA (avg)
1.94
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
0.94
Tax Ratio
29.75%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
12.15%
ROCE (avg)
25.12%
ROE (avg)
0
Valuation key factors
Factor
Value
P/E Ratio
15
Industry P/E
Price to Book Value
4.30
EV to EBIT
11.73
EV to EBITDA
10.77
EV to Capital Employed
2.80
EV to Sales
3.07
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
23.89%
ROE (Latest)
27.86%
Technicals key factors
Indicator
Weekly
Monthly
MACD
RSI
Bollinger Bands
KST
Dow Theory
OBV
Shareholding Snapshot : Jun 2026
Shareholding Compare (%holding) 
Majority shareholders
Promoters
Pledged Promoter Holdings
None
Mutual Funds
Held by 1 Schemes (0.25%)
FIIs
Held by 20 FIIs (3.06%)
Promoter with highest holding
Dharm Deo Choudhary (37.17%)
Highest Public shareholder
Sanshi Fund-i (2.64%)
Individual Investors Holdings
13.57%
Half Yearly Results Snapshot (Standalone) - Mar'26
Mar'26
Mar'25
Change(%)
Net Sales
16.07
15.26
5.31%
Operating Profit (PBDIT) excl Other Income
5.53
4.33
27.71%
Interest
0.37
0.25
48.00%
Exceptional Items
0.00
0.00
Standalone Net Profit
3.19
3.02
5.63%
Operating Profit Margin (Excl OI)
34.41%
28.37%
6.04%
Values in Rs Cr.
Net Sales
Not Applicable: The company has declared_date for only one period
Standalone Net Profit
Not Applicable: The company has declared_date for only one period
Annual Results Snapshot (Standalone) - Mar'26
Mar'26
Mar'25
Change(%)
Net Sales
35.31
28.89
22.22%
Operating Profit (PBDIT) excl Other Income
10.90
7.65
42.48%
Interest
0.62
0.61
1.64%
Exceptional Items
0.00
-0.08
100.00%
Standalone Net Profit
6.73
5.00
34.60%
Operating Profit Margin (Excl OI)
30.87%
26.48%
4.39%
Values in Rs Cr.
Net Sales
YoY Growth in year ended Mar 2026 is 22.22% vs 77.68% in Mar 2025
Standalone Net Profit
YoY Growth in year ended Mar 2026 is 34.60% vs 150.00% in Mar 2025
About Avience Biomedicals Ltd 
Avience Biomedicals Ltd
Micro Cap
Healthcare Services
Avience Biomedicals Limited was originally incorporated as Private Limited Company as "Avience Biomedicals Private Limited" on December 23, 2019 with the Registrar of Companies, Delhi. Later, Company's status got converted into a Public Limited Company, the name of the Company was changed to "Avience Biomedicals Limited" and fresh Certificate of incorporation dated September 3, 2024, was issued by the Registrar of Companies, Delhi.
Company Coordinates 
No Company Details Available






